Back to search

Article

Individualized active surveillance for carbapenem-resistant microorganisms using Xpert Carba-R in intensive care units: A single center, before-after study

2023-02-07

Abstract excerpt

<h4>Background: </h4> Carbapenem antibiotics are widely used in intensive care units (ICU), and the prevalence of carbapenem-resistant microorganisms (CRO) has increased, forming a major threat to inpatients that urgently requires improved surveillance. This study aimed to assess the role of individualized active surveillance of carbapenem resistance genes on CRO risk. Methods A total of 3,765 patients were admit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
112e7c72-c33f-5f32-8e1f-3f79e8c35602
DOI
10.21203/rs.3.rs-2532367/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Individualized active surveillance for carbapenem-resistant microorganisms using Xpert Carba-R in intensive care units: A single center, before-after studyDOI 10.21203/rs.3.rs-2532367/v1
Risk factors and outcomes of carbapenem-resistant Escherichia coli nosocomial infections in a Chinese teaching hospital: A retrospective study from 2013 to 2020Semantic proximity
Active screening and Molecular Epidemiology Characteristics of fecal colonization of Carbapenem resistance Enterobacterales from Intensive Care Units wards in a Tertiary Hospital in Shanghai, ChinaSemantic proximity
Molecular epidemiological characteristics of carbapenem-resistant Enterobacter cloacae complexSemantic proximity
Characterization of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa carrying multiple carbapenemase genes-Antimicrobial Resistance Laboratory Network, 2018-2022.Semantic proximity
Antimicrobial resistance patterns of WHO priority pathogens isolated in hospitalized patients in Japan: A tertiary centre observational studySemantic proximity
Genomic characteristics of clinical carbapenem-resistant Escherichia coli isolates in a tertiary hospital, 2013–2021Semantic proximity
Carbapenem-Resistant <em>Klebsiella</em> spp. in Healthcare-Associated Infections: a Narrative Review of Global Epidemiology, Resistance Mechanisms, and Clinical Outcomes (2020–2025)Semantic proximity
Genomic Characterization of Carbapenemase-Producing Enterobacteriaceae Using Whole Genome Sequencing DataSemantic proximity
Evaluation and analysis of multidrug resistance- and hypervirulence-associated genes in carbapenem-resistant Pseudomonas aeruginosa strains among children in an area of China for five consecutive yearsSemantic proximity
Risk factors and molecular characterization of carbapenem resistant Escherichia coli recovered from a tertiary hospital in Fujian, China from 2021 to 2023Semantic proximity
Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment optionsSemantic proximity
Genomic Characteristics and Risk Factor Analysis of Carbapenem-non-susceptible pseudomonas aeruginosa Causing Bacteremia in a Tertiary Hospital (2014-2023)Semantic proximity
Select a neighboring publication to make it the new centre.